Child resistant packaging

The Medicines (Child Safety) Regulations (SI 2003/2317) came into force on 1 October 2003. Medicines containing aspirin, paracetamol, and more than 24 mg of elemental iron must be placed on the market in packaging which has been shown to be child resistant.

The following information is available:
 
› Guidance on compliance with the Medicines (Child Safety) Regulations 2003 (167Kb)  - this document provides general information on the issues which should be considered when submitting applications for medicines required by The Medicines (Child Safety) Regulations 2003 to be packaged in containers resistant to opening by children.
› Question and answer briefing  (89Kb)
› Consultation letter MLX 291  - original consultation letter (183Kb)
  
Contact for further information 
For further information on this part of our site please contact Jan MacDonald, telephone 020 7084 2267, Room 14-107, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, e-mail info@mhra.gsi.gov.uk.


Page last modified: 18 August 2008